Departamento de Tocoginecologia, Universidade Estadual de Campinas Faculdade de Ciencias Medicas, Campinas, Sao Paulo, Brazil.
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneve, Switzerland.
BMJ Open. 2024 Oct 14;14(10):e086723. doi: 10.1136/bmjopen-2024-086723.
There are limited global data on ectopic pregnancy (EP) and molar pregnancy (MP), making it important to understand their epidemiology and management across different regions. Our study aimed to describe their prevalence for both conditions, severity of their complications and management among women in selected health facilities across 17 countries in Africa and Latin America and the Caribbean (LAC).
This is a secondary analysis of the WHO multi-country survey on abortion. Data were collected from 280 healthcare facilities across 11 countries in Africa and 6 in LAC. Sociodemographic information, signs and symptoms, management and clinical outcomes were extracted from medical records. Facility-level data on post-abortion care (PAC) capabilities were also collected, and facilities were classified accordingly. χ or Fisher's exact tests were used to compare categorical data.
The total number of women with EP and MP across both regions was 9.9% (2 415/24 424) where EP accounted for 7.8% (1 904/24 424) and MP for 2.1% (511/24 424). EP presented a higher severity of complications than MP. At admission, 49.8% of EP had signs of peritoneal irritation. The most common surgical management for EP was laparotomy (87.2%) and for MP, uterine evacuation (89.8%). Facilities with higher scores in infrastructure and capability to provide PAC more frequently provided minimal invasive management using methotrexate/other medical treatment (34.9%) and laparoscopy (5.1%).
In Africa and LAC, EP and MP cause significant maternal morbidity and mortality. The disparity in the provision of good quality care highlights the need to strengthen the implementation of evidence-based recommendations in the clinical and surgical management of EP and MP.
全球关于宫外孕(EP)和葡萄胎(MP)的数据有限,因此了解不同地区的流行病学和管理方法非常重要。我们的研究旨在描述这两种疾病在非洲和拉丁美洲及加勒比地区(LAC) 17 个国家选定医疗机构的妇女中的患病率、严重并发症以及管理方法。
这是世卫组织关于堕胎的多国家调查的二次分析。数据来自非洲 11 个国家和 LAC 的 6 个国家的 280 家医疗机构。从病历中提取社会人口学信息、体征和症状、管理和临床结局。还收集了关于流产后护理(PAC)能力的设施级数据,并相应进行了分类。使用 χ 或 Fisher 确切检验比较分类数据。
两个地区的 EP 和 MP 总人数为 9.9%(2415/24424),其中 EP 占 7.8%(1904/24424),MP 占 2.1%(511/24424)。EP 的并发症严重程度高于 MP。入院时,49.8%的 EP 有腹膜刺激征。EP 最常见的手术治疗是剖腹手术(87.2%),MP 最常见的是子宫排空(89.8%)。基础设施得分较高且有能力提供 PAC 的设施更常采用甲氨蝶呤/其他药物治疗(34.9%)和腹腔镜(5.1%)进行微创管理。
在非洲和 LAC,EP 和 MP 导致严重的产妇发病率和死亡率。在提供优质护理方面的差异突显了加强实施 EP 和 MP 的临床和外科管理中基于证据的建议的必要性。